New Technology at Our Practice
More Ways to Protect Your Vision
Two new treatments for macular degeneration and glaucoma, now available at Ophthalmology Associates of San Antonio.
Two new treatments for macular degeneration and glaucoma, now available at Ophthalmology Associates of San Antonio.
Dry age-related macular degeneration (AMD) is one of the leading causes of vision loss in people over 65. For years, care meant monitoring and vitamins. Valeda is a non-invasive light therapy, FDA-authorized in 2024, that delivers targeted red, amber, and near-infrared light to the retina to support the health of retinal cells.
What to expect:
4 minutes per eye.
Painless. You sit comfortably at the device, with no injections and no surgery.
A series of sessions over several weeks, with follow-up treatment cycles
Valeda is for early to intermediate dry AMD. It is not a cure, and it is not a treatment for wet AMD.
Lowering eye pressure is the main way glaucoma is treated. Voyager DSLT is a laser that helps the eye drain fluid more effectively, lowering pressure in patients with ocular hypertension or open-angle glaucoma. Automated eye tracking delivers 120 laser pulses in about 2.4 seconds per eye, with no contact lens and no touching the eye.
2.4 seconds per eye
Contact-free comfort
Covered by most insurance plans and Medicare
First practice in San Antonio to offer it
In a clinical trial, 62% of patients treated with Voyager DSLT were free of glaucoma medication 12 months later.
Our team can help you find out whether Valeda or Voyager DSLT is right for you.